Effects of phospholipase A2, free fatty acids and 2-lysolecithin on the crystallization of cholesterol in gallbladder bile

European Journal of Clinical Investigation

Volumn 30, Issue 8, 2000, Pages 715-721

  Schone A ^a   Jungst D ^a   Meyer, G ^a   Hernandez Richter, T ^a   Fischer, Sven ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Crystal growth assay; Crystal observation time; Gas liquid chromatography; Phosphatidylcholines

Indexed keywords

CHOLESTEROL; FATTY ACID; LYSOPHOSPHATIDYLCHOLINE; PHOSPHOLIPASE A2; ARACHIDONIC ACID; CARBON; PHOSPHOLIPASE A;

ADULT; AGED; ARTICLE; BILE; CHOLESTEROL STONE; CLINICAL ARTICLE; CRYSTALLIZATION; ENZYME ACTIVITY; FEMALE; GALLBLADDER; HUMAN; MALE; PRIORITY JOURNAL; CHEMISTRY; CHOLELITHIASIS; ENZYMOLOGY; METABOLISM; MIDDLE AGED; TIME;

ADULT; AGED; ARACHIDONIC ACID; BILE; CARBON ISOTOPES; CHOLELITHIASIS; CHOLESTEROL; CRYSTALLIZATION; FATTY ACIDS, NONESTERIFIED; FEMALE; GALLBLADDER; HUMANS; LYSOPHOSPHATIDYLCHOLINES; MALE; MIDDLE AGED; PHOSPHOLIPASES A; TIME FACTORS;

EID: 0033624289     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2000.00703.x     Document Type: Article

References (29)

1. 1 Apstein MD, Carey MC. Pathogenesis of cholesterol gallstones: a parsimonious hypothesis. Eur J Clin Invest 1996;26:343-52.
2. 2 LaMont JT, Smith BF, Moore JRL. Role of gallbladder mucin in the pathophysiology of gallstones. Hepatology 1984;4(Suppl.):51S-56S.
3. 3 Harvey PRC, Upadhya GA, Strasberg SM. Immunoglobulins as nucleating proteins in the gallbladder bile of patients with cholesterol gallstones. J Biol Chem 1991;266:13996-4003.
4. 4 Nakano T, Yanagisawa J, Nakayama F. Phospholipase activity in human bile. Hepatology 1988;8:1560-4.
5. 5 Groen AK, Noordam C, Drapers JAG, Egbers P, Hoek FJ, Tytgat GNJ. An appraisal of the role of biliary phospholipases in the pathogenesis of gallstone disease. Biochim Biophys Acta 1989;1006:179-82.
6. 6 Shoda J, Ueda T, Ikegami T, Matsuzaki Y, Satoh S, Kano M et al. Increased biliary group II phospholipase A2 and altered gallbladder bile in patients with multiple cholesterol stones. Gastroenterology 1997;112:2036-47.
7. 7 Kano M, Shoda J, Irimura T, Ueda T, Iwasaki R, Urasaki T et al. Effects of long-term ursodeoxycholate administration on expression levels of secretory low-molecular-weight phospholipase A2 and mucin genes in gallbladders and biliary composition in patients with multiple cholesterol stones. Hepatology 1998;28:302-13.
8. 8 Nakayama F, Johnston CG. Fractionation of bile lipids with silicic acid colunm chromatography. J Lab Clin Med 1962;59:364-70.
9. 9 Nakayama F. Quantitative microanalysis of bile. J Lab Clin Med 1967;69:594-609.
10. 10 Mingrone G, Greco AV, Passi S. The possible role of free fatty acids in the pathogenesis of cholesterol gallstones in man. Biochim Biophys Acta 1983;751:138-44.
11. 11 Mingrone G, Greco AV, Finotti E, Passi S. Free fatty acids: a stimulus for mucin hypersecretion in cholesterol gallstone biles. Biochim Biophys Acta 1988;958: 52-9.
12. 12 Halpern Z, Goldman G, Peled Y, Konikoff F, Rattan J, Lichtenberg D et al. Free fatty acids have nucleating effects in model biles. Liver 1992;12:107-11.
13. 13 Halpern Z, Rubin M, Harach G, Grotto I, Mosel A, Dvir A et al. Bile and plasma lipid composition in non-obese normolipidemic subjects with and without cholesterol gallstones. Liver 1993;13:246-52.
14. 14 Neiderhiser DH, Roth HP. Effect of phospholipase A on cholesterol solubilization by lecithin in a bile salt solution. Gastroenterology 1970;58:26-31.
15. 15 Tera H. Stratification of human gallbladder bile in vivo. Acta Chir Scand 1960;256(Suppl.):4-85.
16. 16 Holan KR, Holzbach T, Hermann RE, Cooperman AM, Claffey WJ. Nucleation time: a key factor in the pathogenesis of cholesterol gallstone disease. Gastroenterology 1979;77: 611-7.
17. 17 Abell LL, Levy BB, Brodie BB, Kendall FE. A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J Biol Chem 1952;195: 357-66.
18. 18 Fiske CH, Subbarow Y. The colorimetric determination of phosphorus. J Biol Chem 1925;66:375-400.
19. 19 Talalay P. Enzymatic analysis of steroid hormones. Biochem Anal 1960;8:119-43.
20. 20 Carey MC. Critical tables for calculating the cholesterol saturation of native bile. J Lipid Res 1978;19:945-55.
21. 21 Bligh EG, Dyer WY. A rapid method of total lipid extraction and purification. Can J Biochem Biophys 1953;37:911-17.
22. 22 Fischer S, Schöne A, Meyer G, Jüngst D. Quantitation of free fatty acids in hepatic and gallbladder bile of patients with cholesterol gallstones. Gastroenterology 1997;112:A505.
23. 23 Hay DW, Cahalane MJ, Timofeyewa N, Carey MC. Molecular species of lecithins in human gallbladder bile. J Lipid Res 1993;34:759-68.
24. 24 Tagesson C, Norrby S, Sjödahl R. The prerequisites for local lysolecithin formation in the human gallbladder. Scand J Gastroenterol 1978;13:417-22.
25. 25 Pattinson NR. Identification of a phosphatidylcholine active phospholipase C in human gallbladder bile. Biochem Biophys Res Comm 1988;150(2):890-6.
26. 26 Pattinson NR, Willis KE. Phospholipase C and diacylglycerollipase in human gallbladder and hepatic bile. Gastroenterology 1990;99:1798-806.
27. 27 Busch N, Holzbach RT. Crystal growth-inhibiting proteins in bile. Hepatology 1990;12:195S-199S.
28. 28 Busch N, Matiuck N, Sahlin S, Pillay P, Holzbach RT. Inhibition and promotion of cholesterol crystallization by protein fractions from normal human gallbladder bile. J Lipid Res 1991;32:695-702.
29. 29 Cetta F. Bile infection documented as initial event in the pathogenesis of brown pigment biliary stones. Hepatology 1986;6:482-9.